A.B.A. interpreted the data from study 1 with input from S.B.O. and R.A.B.
Questionnaire data from Study 2 (N = 94) was used to test the model with PLS-SEM.
Using data from Study 1, we established that feelings of stiffness at baseline correlated significantly with FEE at 60 N (rho = 0.58, p = 0.025).
Dr Fiona Godlee, BMJ editor-in-chief, said publication of the reanalysed data from study 329 "sets the record straight" and "shows the extent to which drug regulation is failing us".
Data from study 3 demonstrated similar findings in that the combination of alendronate and HRT also enhanced BMD values.
Data from study II demonstrated that family resemblance in afternoon cortisol was accounted for by underlying shared environmental factors, but not underlying genetic factors.
On the basis of the exploratory data from study 1, a second phase II study (study 9) was designed to determine whether repeated administration of lanicemine over 3 weeks at an interval of three infusions per week would consolidate and extend the therapeutic benefits observed from a single administration.
C.E.R., K.J.M. and J.R.H. interpreted the data from study 2. A.B.A. drafted the paper and most of the supplementary materials, with pertinent sections from study 2 drafted by C.E.R. and J.R.H. S.B.O., R.A.B., C.E.R., K.J.M., J.G. and J.R.H. provided critical revision of the paper.
Data from study protocols and informed consents were extracted and analyzed.
Additional demographic data from study participants is summarized in Table 1.
Analysis of data from Study 2 showed a significant interaction between Phytophthora species and sample time (F2,20 = 27.18, p < 0.0001; Figure 4).
